Stenocare A/S (CPH:STENO)
Denmark
· Delayed Price · Currency is DKK 0.3740
+0.0060 (1.63%)
Apr 1, 2025, 3:24 PM CET
Stenocare Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 2.23 | 3.99 | 4.49 | 1.89 | 0.2 | Upgrade
|
| Revenue Growth (YoY) | -44.10% | -11.06% | 137.54% | 852.38% | -95.98% | Upgrade
|
| Cost of Revenue | 7.66 | 10.18 | 10.9 | 7.9 | 6.19 | Upgrade
|
| Gross Profit | -5.42 | -6.18 | -6.41 | -6.01 | -6 | Upgrade
|
| Selling, General & Admin | 5.76 | 6.38 | 6.81 | 7.23 | 5.84 | Upgrade
|
| Operating Expenses | 14.62 | 9.76 | 10.12 | 8.07 | 6.08 | Upgrade
|
| Operating Income | -20.04 | -15.95 | -16.53 | -14.08 | -12.07 | Upgrade
|
| Interest Expense | -1.54 | -2.88 | -1.29 | -0.21 | -1.68 | Upgrade
|
| Interest & Investment Income | 0.03 | - | 0.02 | 0.03 | 0.03 | Upgrade
|
| Earnings From Equity Investments | -0 | - | -0.08 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -21.55 | -18.82 | -17.89 | -14.26 | -13.72 | Upgrade
|
| Asset Writedown | -5.1 | - | - | - | - | Upgrade
|
| Other Unusual Items | -7.95 | - | - | - | - | Upgrade
|
| Pretax Income | -34.6 | -18.82 | -17.89 | -14.26 | -13.72 | Upgrade
|
| Income Tax Expense | -0.11 | -1.25 | -1.58 | -1.53 | -1.93 | Upgrade
|
| Net Income | -34.49 | -17.57 | -16.3 | -12.73 | -11.79 | Upgrade
|
| Net Income to Common | -34.49 | -17.57 | -16.3 | -12.73 | -11.79 | Upgrade
|
| Shares Outstanding (Basic) | 19 | 14 | 11 | 12 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 14 | 11 | 12 | 11 | Upgrade
|
| Shares Change (YoY) | 38.17% | 22.09% | -2.22% | 11.00% | 17.45% | Upgrade
|
| EPS (Basic) | -1.79 | -1.26 | -1.43 | -1.09 | -1.12 | Upgrade
|
| EPS (Diluted) | -1.79 | -1.26 | -1.43 | -1.09 | -1.12 | Upgrade
|
| Free Cash Flow | -7.19 | -10.22 | -15.97 | -16.61 | -31.24 | Upgrade
|
| Free Cash Flow Per Share | -0.37 | -0.73 | -1.40 | -1.42 | -2.97 | Upgrade
|
| Gross Margin | -243.00% | -154.90% | -142.77% | - | - | Upgrade
|
| Operating Margin | -897.88% | -399.38% | -368.13% | -744.89% | -6082.87% | Upgrade
|
| Profit Margin | -1545.07% | -440.03% | -363.13% | -673.67% | -5939.17% | Upgrade
|
| Free Cash Flow Margin | -321.91% | -255.89% | -355.68% | -879.03% | -15743.53% | Upgrade
|
| EBITDA | -11.18 | -12.56 | -13.22 | -12.99 | -11.83 | Upgrade
|
| EBITDA Margin | - | - | -294.35% | - | - | Upgrade
|
| D&A For EBITDA | 8.86 | 3.38 | 3.31 | 1.09 | 0.24 | Upgrade
|
| EBIT | -20.04 | -15.95 | -16.53 | -14.08 | -12.07 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.